Gene · 1438
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multimodal cartography of human lymphopoiesis reveals B and T/NK/ILC lineages are subjected to differential regulation. | iScience | 2023 | 37766969 | PubTator, text mining | PubMed |
| Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster. | Int J Mol Sci | 2023 | 37762484 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways. | J Biol Chem | 2023 | 37739035 | PubTator, text mining | PubMed |
| Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo. | Cell Mol Life Sci | 2023 | 37728691 | PubTator, text mining | PubMed |
| Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome. | Genome Med | 2023 | 37726845 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2). | Ann Rheum Dis | 2023 | 37699654 | PubTator, text mining | PubMed |
| Angiotensin II modulates THP-1-like macrophage phenotype and inflammatory signatures via angiotensin II type 1 receptor. | Front Cardiovasc Med | 2023 | 37692050 | PubTator, text mining | PubMed |
| Increase in brain glycogen levels ameliorates Huntington's disease phenotype and rescues neurodegeneration in Drosophila. | Dis Model Mech | 2023 | 37681238 | PubTator, text mining | PubMed |
| Cell-targeted vaccines: implications for adaptive immunity. | Front Immunol | 2023 | 37662903 | PubTator, text mining | PubMed |
| Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions. | Mol Ther Oncolytics | 2023 | 37654973 | PubTator, text mining | PubMed |
| A new era of macrophage-based cell therapy. | Exp Mol Med | 2023 | 37653035 | PubTator, text mining | PubMed |
| Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype. | Nat Commun | 2023 | 37633924 | PubTator, text mining | PubMed |
| Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. | Nat Commun | 2023 | 37612300 | PubTator, text mining | PubMed |
| Whole lung lavage decreases physiological dead space in patients with pulmonary alveolar proteinosis: two case reports. | J Med Case Rep | 2023 | 37596611 | PubTator, text mining | PubMed |
| FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells. | FEBS Open Bio | 2023 | 37584250 | PubTator, text mining | PubMed |
| RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. | J Clin Invest | 2023 | 37581927 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
| Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet. | Sci Rep | 2023 | 37558676 | PubTator, text mining | PubMed |
| HIB/SPOP inhibits Ci/Gli-mediated tumorigenesis by modulating the RNA Polymerase II components stabilities. | iScience | 2023 | 37554435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1438/papers?page=7